H. Taegtmeyer, M. E. Young, G. D. Lopaschuk, and E. D. Abel,

V. Usmar, Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association, Circ Res, vol.118, issue.10, pp.1659-701, 2016.

G. Rosano, M. Fini, G. Caminiti, and G. Barbaro, Cardiac metabolism in myocardial ischemia, Curr Pharm Des, vol.14, issue.25, pp.2551-62, 2008.

W. C. Stanley, G. D. Lopaschuk, J. L. Hall, and J. G. Mccormack, Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions, Cardiovasc Res, vol.33, issue.2, pp.243-57, 1997.

A. Manrique, Insuffisance cardiaque et viabilité myocardique, 2018.

. Jm-fauvel,

. Faculté-de-médecine-de-toulouse, , 2009.

. Faculté-de-médecine-de-toulouse,

K. Thygesen, J. S. Alpert, A. S. Jaffe, B. R. Chaitman, J. J. Bax et al.,

, universal definition of myocardial infarction, 2018.

, Kardiol Pol, vol.76, issue.10, pp.1383-415, 2018.

A. Meiltz and . Sc, L'ischémie myocardique silencieuse : un silence assourdissant, Rev Med Suisse, vol.1, 2005.

P. C. Deedwania and E. V. Carbajal, Silent myocardial ischemia. A clinical perspective, Arch Intern Med, vol.151, issue.12, pp.2373-82, 1991.

P. Valensi, L. Lorgis, and Y. Cottin, Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: a review of the literature, Arch Cardiovasc Dis, vol.104, issue.3, pp.178-88, 2011.

H. Feringa, S. E. Karagiannis, R. Vidakovic, A. Elhendy, F. J. Ten-cate et al., The prevalence and prognosis of unrecognized myocardial infarction and silent myocardial ischemia in patients undergoing major vascular surgery. Coron Artery Dis, vol.18, pp.571-577, 2007.

, Évaluation de l'imagerie cardiaque non invasive dans le diagnostic des coronaropathies chroniques stables. Haute autorité de santé, HAS, 2016.

M. Pr and . Salma, Dépistage non invasif de l'ischémie myocardique, 2014.

U. P. Clamart and . Sud,

, Imagerie cardiaque non invasive : apport spécifique en clinique des nouvelles modalités (II), Rev Med Suisse, vol.4, pp.1311-1318, 2008.

A. Marique, Les tests d'ischémie, 2018.

F. Rouzet, Scintigraphie myocardique de perfusion, 2018.

G. Mowatt, L. Vale, M. Brazzelli, R. Hernandez, A. Murray et al., Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction, iii-iv, vol.8, pp.1-207, 2004.

C. Jaarsma, T. Leiner, S. C. Bekkers, H. J. Crijns, J. E. Wildberger et al., Diagnostic performance of noninvasive myocardial perfusion imaging using singlephoton emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis, J Am Coll Cardiol, vol.59, pp.1719-1747, 2012.

T. Leclercq, Echographie cardiaque de stress: Dépistage de l'ischémie myocardique, 2018.

M. H. Heijenbrok-kal, K. E. Fleischmann, and M. Hunink, Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance, Am Heart J, vol.154, issue.3, pp.415-438, 2007.

G. Korosoglou, S. Giusca, G. Gitsioudis, C. Erbel, and H. A. Katus, Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification, Front Physiol, vol.5, p.291, 2014.

A. Micheau and D. H. , Anatomie du coeur : illustrations et planches anatomiques, modèle 3D et photographies de dissection, 2017.

C. Hacking and . Goel, Cardiac segmentation model, 2017.

M. D. Cerqueira, N. J. Weissman, V. Dilsizian, A. K. Jacobs, S. Kaul et al., Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on, Clinical Cardiology of the American Heart Association. Circulation, vol.105, issue.4, pp.539-581, 2002.

H. A. Ziessman, J. P. O'malley, J. H. Thrall, and F. H. Fahey, Nuclear medicine the requisites, 2014.

S. Basu, S. Hess, N. Braad, P. Olsen, B. B. Inglev et al., The Basic Principles of FDG-PET/CT Imaging, PET Clin, vol.9, issue.4, pp.355-70, 2014.

O. Molchanova-cook and W. Chen, Role of FDG-PET in Evaluation of Myocardial Viability, PET Clin, vol.6, issue.4, pp.383-91, 2011.

M. Kobylecka, J. M?czewska, K. Fronczewska-wieniawska, T. Mazurek, M. T. P?azi?ska et al., Myocardial viability assessment in 18FDG PET/CT study (18FDG PET myocardial viability assessment), Nucl Med Rev Cent East Eur, vol.15, issue.1, pp.52-60, 2012.

, EANM Guidelines. Myocardial Viability. EANM Guide, 2019.

E. Inglese, L. Leva, R. Matheoud, G. Sacchetti, C. Secco et al., Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT, J Nucl Med, vol.48, issue.10, pp.1662-1671, 2007.

R. J. Gropler, B. A. Siegel, K. J. Lee, S. M. Moerlein, D. J. Perry et al., Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans, J Nucl Med, vol.31, issue.11, pp.1749-56, 1990.

D. Jain, Z. He, and V. Lele, Cardiac Hot Spot Imaging With (18)FDG. Semin Nucl Med, vol.44, pp.375-85, 2014.

R. Minamimoto, M. Morooka, Y. Miyata, K. Ito, M. Okasaki et al., Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening, Ann Nucl Med, vol.27, issue.6, pp.572-80, 2013.

P. Zanco, A. Desideri, G. Mobilia, S. Cargnel, E. Milan et al., Effects of left bundle branch block on myocardial FDG PET in patients without significant coronary artery stenoses, J Nucl Med, vol.41, issue.6, pp.973-980, 2000.

F. Erthal, D. Juneau, S. P. Lim, G. Dwivedi, P. B. Nery et al., Imaging of cardiac sarcoidosis, Q J Nucl Med Mol Imaging, vol.60, issue.3, pp.252-63, 2016.

A. H. Maurer, M. Burshteyn, L. P. Adler, and R. M. Steiner, How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT, Radiographics, vol.31, issue.5, pp.1287-305, 2011.

C. Altehoefer, J. Dahl, R. Bares, G. L. Stöcklin, and U. Büll, Metabolic mismatch of septal beta-oxidation and glucose utilization in left bundle branch block assessed with PET, J Nucl Med, vol.36, issue.11, pp.2056-2065, 1995.

H. Fujii, M. Ide, S. Yasuda, W. Takahashi, A. Shohtsu et al., Increased FDG uptake in the wall of the right atrium in people who participated in a cancer screening program with whole-body PET, Ann Nucl Med, vol.13, issue.1, pp.55-64, 1999.

H. Taegtmeyer, M. E. Young, G. D. Lopaschuk, E. D. Abel, H. Brunengraber et al., Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association, Circ Res, vol.118, issue.10, pp.1659-701, 2016.

E. Inglese, L. Leva, R. Matheoud, G. Sacchetti, C. Secco et al., Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT, J Nucl Med, vol.48, issue.10, pp.1662-1671, 2007.

G. Rosano, M. Fini, G. Caminiti, and G. Barbaro, Cardiac metabolism in myocardial ischemia, Curr Pharm Des, vol.14, issue.25, pp.2551-62, 2008.

P. Camici, E. Ferrannini, and L. H. Opie, Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography, Prog Cardiovasc Dis, vol.32, issue.3, pp.217-255, 1989.

A. H. Maurer, M. Burshteyn, L. P. Adler, and R. M. Steiner, How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT, Radiographics, vol.31, issue.5, pp.1287-305, 2011.

R. J. Gropler, B. A. Siegel, K. J. Lee, S. M. Moerlein, D. J. Perry et al., Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans, J Nucl Med, vol.31, issue.11, pp.1749-56, 1990.

K. Dou, B. Xie, X. Gao, Y. Li, Y. Yang et al., Use of resting myocardial 18F-FDG imaging in the detection of unstable angina, Nucl Med Commun, vol.36, issue.10, pp.999-1006, 2015.

B. Nagy, R. Grella, D. Garza, A. Van-tosh, and S. F. Horowitz, Silent myocardial ischemia during PET, J Nucl Med, vol.36, issue.6, pp.1034-1040, 1995.

O. Molchanova-cook and W. Chen, Role of FDG-PET in Evaluation of Myocardial Viability, PET Clin, vol.6, issue.4, pp.383-91, 2011.

R. Slart, J. J. Bax, E. E. Van-der-wall, D. J. Van-veldhuisen, P. L. Jager et al., Nuclear cardiac imaging for the assessment of myocardial viability, Neth Heart J, vol.13, issue.11, pp.408-423, 2005.

I. Sarikaya, A. H. Elgazzar, M. A. Alfeeli, P. N. Sharma, and A. Sarikaya, Status of F-18 fluorodeoxyglucose uptake in normal and hibernating myocardium after glucose and insulin loading, J Saudi Heart Assoc, vol.30, issue.2, pp.75-85, 2018.

K. Fukuchi, H. Ohta, K. Matsumura, and Y. Ishida, Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies, Br J Radiol, vol.80, issue.949, pp.3-11, 2007.

C. Ayoub, E. Pena, H. Ohira, A. Dick, E. Leung et al., Advanced imaging of cardiac sarcoidosis, Curr Cardiol Rep, vol.17, issue.4, p.17, 2015.

F. Erthal, D. Juneau, S. P. Lim, G. Dwivedi, P. B. Nery et al., Imaging of cardiac sarcoidosis, Q J Nucl Med Mol Imaging, vol.60, issue.3, pp.252-63, 2016.

G. Mowatt, L. Vale, M. Brazzelli, R. Hernandez, A. Murray et al., Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction, iii-iv, vol.8, pp.1-207, 2004.

J. W. Lee, S. H. Hwang, D. Y. Kim, K. Han, and Y. M. , Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular Carcinoma, Clin Nucl Med, vol.42, issue.1, pp.35-40, 2017.

C. Marcassa, M. Galli, A. Cuocolo, F. Scappellato, S. Maurea et al., Restredistribution thallium-201 and rest technetium-99m-sestamibi SPECT in patients with stable coronary artery disease and ventricular dysfunction, J Nucl Med, vol.38, issue.3, pp.419-443, 1997.

A. Rominger, T. Saam, S. Wolpers, C. C. Cyran, M. Schmidt et al., 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease, J Nucl Med, vol.50, issue.10, pp.1611-1631, 2009.

M. D. Cerqueira, N. J. Weissman, V. Dilsizian, A. K. Jacobs, S. Kaul et al., Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on, Clinical Cardiology of the American Heart Association. Circulation, vol.105, issue.4, pp.539-581, 2002.

A. Jamiel, M. Ebid, A. M. Ahmed, D. Ahmed, and A. Mh, The role of myocardial viability in contemporary cardiac practice, Heart Fail Rev, vol.22, issue.4, pp.401-414, 2017.

M. Saponara, V. Ambrosini, M. Nannini, L. Gatto, A. Astolfi et al., 18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature, Ther Adv Med Oncol, vol.10, p.1758835918793569, 2018.

K. Rahbar, H. Seifarth, M. Schäfers, L. Stegger, A. Hoffmeier et al., Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT, J Nucl Med, vol.53, issue.6, pp.856-63, 2012.

H. Fujii, M. Ide, S. Yasuda, W. Takahashi, A. Shohtsu et al., Increased FDG uptake in the wall of the right atrium in people who participated in a cancer screening program with whole-body PET, Ann Nucl Med, vol.13, issue.1, pp.55-64, 1999.

P. Zanco, A. Desideri, G. Mobilia, S. Cargnel, E. Milan et al., Effects of left bundle branch block on myocardial FDG PET in patients without significant coronary artery stenoses, J Nucl Med, vol.41, issue.6, pp.973-980, 2000.

R. Minamimoto, M. Morooka, Y. Miyata, K. Ito, M. Okasaki et al., Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening, Ann Nucl Med, vol.27, issue.6, pp.572-80, 2013.

J. R. Garcia, M. Soler, S. Fuertes, E. Riera, A. Moreno et al., Incidence of focal myocardial (18)F-FDG uptake and correlation with coronary calcifications by PET/CT, Rev Esp Med Nucl, vol.30, issue.1, pp.8-13, 2011.

D. Mariano-goulart, D. Ilonca, and A. Bourdon, Diagnosis of silent myocardial ischemia during the staging of HIV-associated lymphoma with FDG PET/CT, Clin Nucl Med, vol.34, issue.10, pp.731-734, 2009.

A. H. Maurer, M. Burshteyn, L. P. Adler, J. P. Gaughan, and R. M. Steiner, Variable cardiac 18FDG patterns seen in oncologic positron emission tomography computed tomography: importance for differentiating normal physiology from cardiac and paracardiac disease, J Thorac Imaging, vol.27, issue.4, pp.263-271, 2012.

J. L. Fleg, G. Gerstenblith, A. B. Zonderman, L. C. Becker, M. L. Weisfeldt et al., Prevalence and prognostic significance of exercise-induced silent myocardial ischemia detected by thallium scintigraphy and electrocardiography in asymptomatic volunteers, Circulation, vol.81, issue.2, pp.428-464, 1990.

A. Sultan, F. Perriard, V. Macioce, D. Mariano-goulart, C. Boegner et al., Evolution of silent myocardial ischaemia prevalence and cardiovascular disease risk factor management in Type 2 diabetes over a 10-year period: an observational study, Diabet Med, vol.34, issue.9, pp.1244-51, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01762635

A. S. Al-oweidi, H. Albabtain, S. M. Kharabsheh, P. Kimme, M. Almustafa et al., Prevalence and predictors of myocardial ischemia by preoperative myocardial perfusion single photon emission computed tomography in patients undergoing noncardiac surgery, Ann Saudi Med, vol.37, issue.6, pp.461-469, 2017.

D. Sarfati, J. Gurney, B. T. Lim, N. Bagheri, A. Simpson et al., Identifying important comorbidity among cancer populations using administrative data: Prevalence and impact on survival, Asia Pac J Clin Oncol, vol.12, issue.1, pp.47-56, 2016.

D. E. Giza, G. Iliescu, S. Hassan, K. Marmagkiolis, and C. Iliescu, Cancer as a Risk Factor for Cardiovascular Disease, Curr Oncol Rep, vol.19, issue.6, p.39, 2017.

D. Mariano-goulart, J. Jacquet, N. Molinari, A. Bourdon, M. Benkiran et al., Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT?, European Journal of Nuclear Medicine and Molecular Imaging, vol.40, issue.2, pp.271-280, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02548086